Cellular response to mycobacteria: Balancing protection and pathology

Trends in Immunology

Volumn 32, Issue 2, 2011, Pages 66-72

  Torrado, Egídio ^a   Robinson, Richard T ^a   Cooper, Andrea M ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN SPECIFICITY; CELL POPULATION; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MYCOBACTERIOSIS; MYCOBACTERIUM; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

ANIMALS; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; T-LYMPHOCYTES;

EID: 79751529842     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2010.12.001     Document Type: Review

References (61)

1. Casanova J., Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 2002, 20:581-620.
2. Tobin D.M., et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 2010, 140:717-730.
3. Cooper A. T cells in mycobacterial infection and disease. Curr. Opin. Immunol. 2009, 21:378-384.
4. Cooper A. Cell mediated immune responses in tuberculosis. Annu. Rev. Immunol. 2009, 27:393-422.
5. Kaufmann S.H. Novel tuberculosis vaccination strategies based on understanding the immune response. J. Intern. Med. 2010, 267:337-353.
6. Wolf A., et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 2008, 205:105-115.
7. Reiley W., et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in mediastinal lymph nodes. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10961-10966.
8. Gallegos A., et al. Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J. Exp. Med. 2008, 205:2359-2368.
9. Wolf A.J., et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 2007, 179:2509-2519.
10. Cooper A.M., Khader S.A. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 2008, 226:191-204.
11. Bhatt K., Salgame P. Host innate immune response to Mycobacterium tuberculosis. J. Clin. Immunol. 2007, 27:347-362.
12. Chen M., et al. A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J. Immunol. 2006, 176:3707-3716.
13. Flynn J., Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 2001, 19:93-129.
14. Chen M., et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 2008, 205:2791-2801.
15. Divangahi M., et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 2009, 10:899-906.
16. Behar S.M., et al. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat. Rev. Microbiol. 2010, 8:668-674.
17. Divangahi M., et al. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat. Immunol. 2010, 11:751-758.
18. Scott-Browne J., et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 2007, 204:2159-2169.
19. Marin N.D., et al. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis (Edinb.) 2010, 90:252-261.
20. Garg A., et al. Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur. J. Immunol. 2008, 38:459-469.
21. Ozeki Y., et al. Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice. Int. Immunol. 2010, 22:179-189.
22. Shafiani S., et al. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 2010, 207:1409-1420.
23. Onishi Y., et al. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10113-10118.
24. Wing K., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008, 322:271-275.
25. Redford P., et al. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur. J. Immunol. 2010, 40:2200-2210.
26. D'Souza C.D., et al. An anti-inflammatory role for gd T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J. Immunol. 1997, 158:1217-1221.
27. Okamoto Yoshida Y., et al. Essential role of IL-17A in the formation of a mycobacterial Infection-induced granuloma in the lung. J. Immunol. 2010, 184:4414-4422.
28. Torrado E., Cooper A.M. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev. 2010, 21:455-462.
29. Khader S., et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 2005, 175:788-795.
30. Aujla S., et al. Th17 cells and mucosal host defense. Semin. Immunol. 2007, 19:377-382.
31. Korf H., et al. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J. Clin. Invest. 2009, 119:1626-1637.
32. Gold M., et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 2010, 8:e1000407.
33. Le Bourhis L., et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat. Immunol. 2010, 11:701-708.
34. Felio K., et al. CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice. J. Exp. Med. 2009, 206:2497-2509.
35. Chiba A., et al. Rapid NKT cell responses are self-terminating during the course of microbial infection. J. Immunol. 2008, 181:2292-2302.
36. Sada-Ovalle I., et al. a-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection. Am. J. Respir. Crit. Care Med. 2010, 182:841-847.
37. Sada-Ovalle I., et al. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-g, and kill intracellular bacteria. PLoS Pathog. 2008, 4:e1000239.
38. Chackerian A., et al. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 2002, 70:6302-6309.
39. Barber D.L., et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
40. Joshi N.S., et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 2007, 27:281-295.
41. Reiley W.W., et al. Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19408-19413.
42. Lazar-Molnar E., et al. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13402-13407.
43. Barber, D.L. et al. (2010) CD4 T cells promote rather than control tuberculosis in the absence of PD-1 mediated inhibition. J. Immunol., in press. doi:10.4049/jimmunol.1003304.
44. Winslow G., et al. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J. Immunol. 2003, 170:2046-2052.
45. Nobrega C., et al. Dissemination of mycobacteria to the thymus renders newly generated T cells tolerant to the invading pathogen. J. Immunol. 2010, 184:351-358.
46. Nobrega C., et al. The thymus as a target for mycobacterial infections. Microbes Infect. 2007, 9:1521-1529.
47. Cooper A.M., et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 1993, 178:2243-2247.
48. Adams L., et al. The study of Mycobacterium leprae in IFN-g gene disrupted mice as a model to explore the immunopathological spectrum of leprosy. J. Infect. Dis. 2002, 185(suppl. 1):S1-S8.
49. Cooper A.M., et al. IFN-g and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol. 2002, 10:221-226.
50. Desvignes L., Ernst J.D. Interferon-g-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 2009, 31:974-985.
51. Cruz A., et al. Pathological role of Interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J. Exp. Med. 2010, 207:1609-1616.
52. Pearl J.E., et al. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J. Immunol. 2004, 173:7490-7496.
53. Holscher C., et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 2005, 174:3534-3544.
54. Villarino A., et al. Understanding the pro- and anti-inflammatory properties of IL-27. J. Immunol. 2004, 173:715-720.
55. Li X., et al. IFN-gamma acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J. Immunol. 2007, 179:939-949.
56. Yoshida H., Miyazaki Y. Regulation of immune responses by Interleukin-27. Immunol. Rev. 2008, 226:234-247.
57. Gumperz J.E., Brenner M.B. CD1-specific T cells in microbial immunity. Curr. Opin. Immunol. 2001, 13:471-478.
58. Cohen N.R., et al. Antigen presentation by CD1: lipids, T cells, and NKT cells in microbial immunity. Adv. Immunol. 2009, 102:1-94.
59. Hava D., et al. Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11281-11286.
60. Fischer K., et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10685-10690.
61. Martin E., et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol. 2009, 7:e54.